|
⚲
|
| Keyboard |
| LaBella Nicholas A Jr
✚
|
|
|---|---|
| CIK # | 0001487698 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001487698] | |
| 4 | [0001487698] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ZyVersa Therapeutics Inc | |
| LaBella Nicholas A Jr |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ZyVersa Therapeutics Inc ZVSA
Common Stock
|
2022-12-12 | Grant | 18,094 | ||
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 29,781 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 29,781 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Warrant (right to buy) · derivative
|
2022-12-12 | Grant | 18,094 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 19,854 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 39,709 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 59,563 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 39,708 | $0.00 |